The net cost to the clinician can vary enormously-i.e. between $80 and $700 for the same type of implant, depending on the manufacturer. Considerations for dental implant prosthodontic costs, so as to compare apples with apples: 1  the specialist training of the prosthodontic clinician; see point 3 below.he net cost to the clinician can range from $80 to $300 for the same implant crown made overseas, depending on the quality of the laboratory engaged; and can range from $350 to $950 for the same implant crown made in Australia, depending on the quality of laboratory engaged.
4 brokers have issued 1-year price objectives for Celator Pharmaceuticals' shares. Their forecasts range from $23.00 to $26.00. On average, they anticipate Celator Pharmaceuticals' stock price to reach $24.50 in the next year.
Otezlaâs market share. Celgene (CELG) expects Otezla to earn revenue of up to $1 billion in 2016 and in the range of $1.5 billionâ$2 billion in 2017. The company has adopted an aggressive pricing strategy to increase Otezlaâs prescriptions and market share. Otezla was launched at a 30% discount to the average price of biologic drugs. Itâs currently priced 35% lower than its competitor drugs. Celgene plans to continue with this pricing strategy to dominate the I&I (immunology and inflammation) space in 2016.